25 of the Best Hematologists Near Me in orange, CA

Dr. Mihaela C. Cristea is a UCI Health hematologist oncologist who specializes in the treatment of gynecologic cancers.She earned her medical degree from the University of Medicine and Pharmacy of Iasi, Romania. She completed a residency in internal medicine at Monmouth Medical Center in Long Branch, N.J. She then completed a fellowship in medical oncology at the University of Florida - Health Science Center, Jacksonville.Her research focuses on evaluating novel therapies to improve patient outcomes in gynecologic malignancies. She has contributed to over 50 peer-reviewed publications in prominent medical journals.Cristea, who also speaks Romanian, brings extensive experience to UCI Health Chao Family Comprehensive Cancer Center. Dr. Cristea is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Lung Cancer, Virilizing Ovarian Tumor, and Endoscopy.

Dr. Mohammadbagher (Mo) Ziari is a board-certified UCI Health hematologist and medical oncologist who specializes in the diagnosis, treatment and management of solid tumors as well as benign and malignant hematological conditions.He earned his medical degree at Shiraz University of Medical Sciences in Shiraz, Iran. Next, he completed a residency in internal medicine at Saint Louis University School of Medicine in Saint Louis, Mo., followed by fellowship training in hematology and oncology at the University of Texas Southwestern in Dallas.Ziari delivers leading-edge cancer therapies, including chemotherapy, endocrine therapy, targeted therapy, monoclonal antibodies and immunotherapy. He is the author of numerous peer-reviewed journal articles.Nickname: Mo. Dr. Ziari is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Breast Cancer, and Paget Disease of the Breast. Dr. Ziari is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Medical Oncology.

Dr. Warren A. Chow is a board-certified UCI Health oncologist who specializes in melanoma and sarcomas. He serves as associate director for clinical services at the UCI Health Chao Family Comprehensive Cancer Center.He received his medical degree from Chicago Medical School at Rosalind Franklin University of Medicine and Science in North Chicago, Ill. He completed an internship and residency in internal medicine at Cedars-Sinai Medical Center in Los Angeles. Next he received fellowship training in medical oncology, hematology and bone marrow transplantation at the City of Hope in Duarte, Calif., where he served nearly 30 years as a clinician and researcher conducting bench-to-bedside studies in both bone and soft-tissue sarcomas.The recipient of numerous research grants from the National Cancer Institute, the U.S. Food and Drug Administration, the Melanoma Research Foundation and many others, Chow has been the principal investigator on more than three dozen clinical trials. He is the author of more than 80 publications and four book chapters, and he serves on the editorial boards of the journalsPLOS ONE,F1000 ResearchandScientific Reports (Nature). Dr. Chow is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Adult Soft Tissue Sarcoma, Liposarcoma, and Chondrosarcoma. Dr. Chow is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine - Internal Medicine.

Dr. Victoria Meucci Villaflor is a board-certified UCI Health medical oncologist who specializes in cancers of the head and neck.She earned her medical degree from Rush Medical College of Rush University Medical Center in Chicago. She completed a residency in internal medicine, followed by a fellowship in hematology and medical oncology, both at Rush University Medical Center.Villaflor focuses on improving outcomes for patients through innovative, multidisciplinary care. Her clinical and research interests center on the integration of immune and targeted therapies in both the metastatic and curative-intent settings. She is particularly focused on enhancing the effectiveness and tolerability of systemic therapies in combination with surgery and/or chemoradiation aiming to personalize treatment approaches and improve long term survival and quality of life.A recognized leader in her field, Villaflor has been honored with the Cardinal Bernardin Humanitarian award and was named a top doctor in Southern California and Chicago. She is a dedicated patient advocate associated with Imerman Angels and Gilda's Club Chicago. Her commitment to research, clinical excellence and compassionate care continue to drive her efforts. Dr. Villaflor is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Salivary Gland Tumors, Gastrostomy, and Thyroidectomy. Dr. Villaflor is board certified in American Board Of Internal Medicine - Medical Oncology.

"Dr. Lauren C. Pinter-Brown is a board-certified, fellowship-trained UCI hematologist-oncologist who specializes in the diagnosis and treatment of patients with lymphomas.A nationally recognized expert, Pinter-Brown has a longstanding interest in malignant lymphoma, with a particular focus on T-cell and skin lymphomas. Her clinical interests also include antiphospholipid, B-cell lymphoma, Hodgkin's lymphoma, mycosis fungoides, non-Hodgkins lymphoma, stem-cell transplant and Waldenstrom's disease.She her medical degree at the David Geffen School of Medicine at UCLA Medical School, followed by an internship and residency in internal medicine at Harbor-UCLA Medical Center. She completed a fellowship in hematology and oncology at the Keck School of Medicine at USC.A prolific clinical investigator, Pinter-Brown has made important contributions to several clinical trials that led to approval of new drugs for the treatment of T-cell lymphoma. Her research focus is on optimizing treatment options for patients with lymphoma, especially cutaneous and T-cell lymphomas. Her primary goal is to care for patients through diagnosis, treatment and beyond and to ensure that they are able ""to live their best life.""". Dr. Pinter-Brown is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Transplant. Dr. Pinter-Brown is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.

Dr. Misagh Karimi is a board-certified hematologist and oncologist who specializes in the treatment of gastrointestinal cancers.Karimi earned his medical degree at George Washington University School of Medicine and Health Sciences in Washington, D.C. At the UC Irvine School of medicine, he completed an internship and residency in internal medicine, followed by fellowships in hematology-oncology and clinical research. He served as an assistant professor at the medical school before joining the Knight Cancer Institute at Oregon Health & Science University in Portland. Before rejoining UCI Health and the School of Medicine, served as an oncologist with City of Hope. Dr. Karimi is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast. Dr. Karimi is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Medical Oncology.

Dr. Deepa Jeyakumar is a board-certified UCI Health hematologist-oncologist who specializes in the diagnosis and treatment of blood cancers, bone marrow transplantation and stem-cell therapy. Her clinical focus is on treating patients with leukemias, lymphomas, myelodysplastic syndromes and myelomas.Jeyakumar earned her medical degree at Temple University’s Lewis Katz School of Medicine in Philadelphia, PA. She completed a residency in internal medicine at the University of Illinois Medical Center in Chicago, followed by a fellowships in hematology/oncology at Tufts Medical Center in Boston, Mass., and bone marrow transplantation at Stanford University in Palo Alto, Calif.She is the author or co-author of numerous publications, posters and abstracts, as well as a chapter on acute myelogenous leukemia in a leading book on care for cancer survivors. Dr. Jeyakumar is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic T-Cell Leukemia (CTCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Jeyakumar is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Medical Oncology.

Dr. Stefan O. Ciurea is a UCI Health hematologist and director of the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center.Ciurea earned his medical degree at Grigore T. Popa University of Medicine and Pharmaceuticals in Iasi, Romania. He completed an internal medicine residency at UPMC Pinnacle Harrisburg in Harrisburg, Pa. He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston.Before joining the Chao Family Comprehensive Cancer Center to lead its program in hematopoietic stem cell transplantation and cellular therapy, Ciurea served for more than a decade on the faculty of the MD Anderson Cancer Center’s Department of Stem Cell Transplantation and Cellular Therapy.Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. He also has served as principal investigator on multiple clinical trials, including investigator-initiated trials. He has been invited to speak at more than 50 meetings and conferences around the world, including as keynote speaker. Dr. Ciurea is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ciurea is board certified in American Board Of Internal Medicine - Hematology.

Dr. Nataliya Mar is a board-certified UCI medical oncologist who specializes in genitourinary malignancies including prostate, bladder, renal and testicular cancer.Mar received her medical degree from SUNY Downstate Medical Center in New York City, N.Y., where she also completed a residency in internal medicine at Lenox Hill Hospital. Next she completed a fellowship in hematology and oncology at the University of Connecticut Health Center in Farmington, Conn.In addition to delivering patient care, Mar is involved in the design and supervising of clinical trials at the UCI Health Chao Family Comprehensive Cancer Center. She has published several articles in peer-reviewed journals related to her work. Dr. Mar is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), and Orchiectomy.

Dr. Arash Rezazadeh Kalebasty is a board-certified UCI Health medical oncologist who specializes in the diagnosis and treatment of genitourinary cancers. His clinical interests include immunotherapy and orther targeted therapies to treat cancers of the prostate, bladder, kidney and testes.He earned his medical degree at Shahid Beheshti University of Medical Sciences in Tehran, Iran. He completed a residency in internal medicine and a fellowship in medical oncology and hematology at Kentucky’s University of Louisville School of Medicine.Rezazadeh has served as principal investigator in numerous clinical trials for genitourinary malignancies, particularly cancers of the bladder and prostate. Some of these trials have led to the approval of novel first-in-class cancer therapies.He has also presented his studies at numerous national and international cancer conferences and has published extensively in his field, with over 100 publications indexed on PubMed. He is a member of the American Society of Clinical Oncology, the European Society for Medical Oncology and the NRG Oncology Genitourinary Committee. He is also an editorial reviewer for the publicationsBladder CancerandAnnals of Case Reports. Dr. Kalebasty is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy. Dr. Kalebasty is board certified in American Board Of Internal Medicine - Medical Oncology.

Dr. Catherine C. Coombs is a board-certified UCI Health hematologist and oncologist who specializes in the management of a hematologic malignancies.Her primary expertise is chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL), which has been her research focus for more than a decade as a principal investigator of numerous clinical trials of novel agents that have improved the care of these patients.Coombs earned her medical degree at the University of Cincinnati College of Medicine in Cincinnati, Ohio. She completed a residency in internal medicine at Duke University Medical Center in Durham, N.C., followed by a fellowship in hematology and oncology at Memorial Sloan Kettering Cancer Center in New York City.She comes to UCI Health and the UCI School of Medicine after serving on the faculty at the University of North Carolina in Chapel Hill, N.C., where she spent six years developing a CLL program before relocating to Southern California to be closer to family.Coombs' research is devoted to developing new drugs and novel drug combinations to treat CLL. She also has an interest in precursor conditions that can lead to blood cancers, including monoclonal B cell lymphocytosis, clonal cytopenia of undetermined significance and clonal hematopoiesis of indeterminate potential.She sees patients inOrange. Dr. Coombs is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Coombs is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Medical Oncology.

Dr. Kiran Naqvi is a board-certified UCI Health hematologic oncologist. Her clinical focus is on acute myeloid leukemia, myelodysplastic syndrome, chronic myelogenous leukemia, bone marrow aspiration and bone marrow transplantation.She earned her medical degree from Dow University of Health Sciences in Karachi, Pakistan. She completed a residency in internal medicine at the University of Illinois Urbana-Champaign and the Carle Foundation Hospital in Urbana, Ill., followed by fellowships in hematology-oncology at Baylor College of Medicine and the University of Texas MD Anderson Cancer Center, both in Houston, Texas. Dr. Naqvi is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndrome (MDS), Leukemia, and Bone Marrow Aspiration. Dr. Naqvi is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.

Dr. Misako Nagasaka is a board-certified UCI Health oncologist who specializes in the diagnosis and treatment of lung and thyroid cancers. Her clinical interests also early-phase clinical trials, medical ethics and survivorship care for patients.She received her medical degree as well as a PhD from St. Marianna University School of Medicine in Kawasaki, Japan. She completed a residency in internal medicine at Mount Sinai Beth Israel Hospital in New York City, followed by a fellowship in hematology and oncology at Wayne State University School of Medicine's Karmanos Cancer Institute in Detroit, Mich.Her research interests include molecular targeted therapy for lung cancer, immunotherapy and ways to improve patient outcomes. Prior to joining UCI Health, she served as an assistant professor and researcher at Wayne State and the Karmanos institute, she was the principal site investigator on more than 20 lung cancer studies.Nagasaka, who is fluent in Japanese, sees patients at the UCI HealthChao Family Comprehensive Cancer Center in Orange. Dr. Nagasaka is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Gastrostomy. Dr. Nagasaka is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine. Dr. Nagasaka is currently accepting new patients.

Dr. Miguel A. Villalona-Calero is a UCI Health medical oncologist who specializes in lung cancer, early phase clinical trials, the use of genomic-driven therapies and immune system treatments to target cancer.An internationally regarded expert in lung cancer and developmental therapeutics, Villalona-Calero serves as deputy director of the UCI Health Chao Family Comprehensive cancer center. As chief of the UC Irvine School of Medicine's Division of Hematology-Oncology, he leads a faculty of more than 70 hematologists and oncologists, including nationally know specialists in many types of cancer.He earned his medical degree from Universidad Nacional Pedro Henriquez Urena in the Dominican Republic, followed by an internship and internal medicine residency at Kings County Hospital Center and the State University of New York Health Science Center in Brooklyn. He completed fellowships in medical oncology at the University of Minnesota Hospitals & Clinics in Minneapolis and the Roswell Park Cancer Institute in Buffalo, N.Y.He also received fellowship training at the University of Texas’ Institute for Drug Development in San Antonio and in health policy leadership at New York University’s Wagner Graduate School of Public Service in New York City. Before joining UCI Health, he served as director of an early phase therapeutics program at City of Hope in Duarte, Calif.Villalona-Calero is widely known for his work in lung cancer and developmental therapeutics, including the design of more effective anticancer agents. His main area of expertise is in translating laboratory science developments into clinical trials for cancer patients. Most recently, his focus has been on targeting cellular deficiencies in DNA repair and finding new ways to use the immune system to attack cancer cells.The author or co-author of more than 140 peer-reviewed publications, Villalona-Calero has been inducted into the American Association for the Advancement of Science and is a fellow of the American College of Physicians. He has led dozens of clinical trials, including early phase studies funded by the National Cancer Institute (NCI) and the National Institutes of Health (NIH). He currently leads a phase 1 clinical trial for non-small cell lung cancer using enhanced natural killer cells, part of a prestigious NCI and NIH R01 grant for developmental cell therapeutics.Villalona, who is fluent in English and Spanish, sees patients inIrvineandOrange. Dr. Villalona-Calero is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Fanconi Anemia, Congenital Aplastic Anemia, Lung Cancer, and Aplastic Anemia. Dr. Villalona-Calero is board certified in American Board Of Internal Medicine - Medical Oncology.

Dr. Jason A. Zell is a board-certified UCI Health hematology-oncology specialist who focuses on the prevention and treatment of colon and other gastrointestinal cancers.He received his medical degree from Nova Southeastern University, Fort Lauderdale, Fla. He completed his internal medicine residency training and hematology-oncology fellowship at the UCI School of Medicine, via the American Board of Internal Medicine Research Pathway.Zell has received extramural research funding from the National Institutes of Health (NIH) to perform genetic epidemiology-based colorectal cancer research, and is principle investigator or co-investigator for several NIH-funded Phase 2 clinical trials involving patients with gastrointestinal malignancies.Within SWOG, a clinical trials organization of the National Clinical Trials Network, he is the cancer control and prevention liaison to the gastrointestinal committee. Additionally, he is national principal investigator for S0820, a large multicenter, randomized Phase 3 trial involving risk reduction among resected colon cancer patients, which is supported by the NIH National Cancer Institute Division of Cancer Prevention, and conducted by SWOG. He has published more than 70 manuscripts and two book chapters. Dr. Zell is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Colonoscopy, and Endoscopy. Dr. Zell is board certified in American Board Of Internal Medicine - Medical Oncology.

Timothy Byun is a Hematologist and an Oncologist practicing medicine in Orange, California. Dr. Byun is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Byun is currently accepting new patients.

Tariq Mahmood is an Oncologist practicing medicine in Orange, California. Dr. Mahmood is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Angiosarcoma, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Mahmood is currently accepting new patients.

Stavroula Otis is a Hematologist Oncology provider practicing medicine in Orange, California. Dr. Otis is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Familial Prostate Cancer. Dr. Otis is currently accepting new patients.

Madhavi Mummaneni is a Hematologist and an Oncologist practicing medicine in Orange, California. Dr. Mummaneni is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, Inflammatory Breast Cancer, and Iron Deficiency Anemia. Dr. Mummaneni is currently accepting new patients.

John Wong is a Hematologist Oncology provider practicing medicine in Orange, California. Dr. Wong is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Adult Soft Tissue Sarcoma, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma. Dr. Wong is currently accepting new patients.

Dr. Angela Fleischman is a UCI Health physician-scientist investigating hematologic malignancies. She integrates her research with the clinical care of patients with these blood disorders.Fleischman earned her medical degree and a PhD in cancer biology from Stanford University in Palo Alto, Calif. Next she completed an internal medicine and a medical oncology fellowship at Oregon Health & Science University in Portland.Fleischman's longstanding interest in blood cell development began during her PhD studies at Stanford. She joined the UCI Health Chao Family Comprehensive Cancer Center as an assistant professor in 2013 and began developing an independent laboratory group focusing on the pathogenesis of myeloproliferative neoplasm (MPN), a chronic leukemia. Her research interests also include a hematologic malignancies and hematopoietic stem cells.Her overarching research goal is to identify what drives disease initiation in MPN and, ultimately, to translate her scientific discoveries into therapies that benefit MPN patients. Dr. Fleischman is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Myelofibrosis, Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Fleischman is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine - Internal Medicine.

Dr. Jennifer B. Valerin is a board-certified UCI Health medical oncologist who specializes in gastrointestinal malignancies and hereditary pancreatic cancer.Valerin earned her medical degree from George Washington University School of Medicine and Health Sciences in Washington, D.C. She completed a residency in internal medicine UCLA, followed by a fellowship in hematology/oncology at MD Anderson Cancer Center in Houston, Texas.She later received a PhD in cancer biology from the University of Texas at Houston/MD Anderson Cancer Center, where her research was focused on resistance mechanisms to inhibitors of the enzyme poly ADP ribose polymerase (PARP) in hereditary pancreatic cancer.Valerin’s research interests include gastrointestinal cancers, hereditary cancers, translational genomics and early-phase clinical trials. She is the author or co-author of numerous papers on studies of pancreatic and other cancers. She also received a Young Investigator Award from the American Society for Clinical Oncology (ASCO) and an award for her basic science research from the American Association for Cancer Research (AACR).Valerin is also fluent in Spanish. Dr. Valerin is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Melanoma, and Ganglioneuroblastoma. Dr. Valerin is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.

Dr. Elizabeth A. Brém is a triple-board certified UCI Health hematologist-oncologist and medical oncologist who specializes in the diagnosis and treatment of lymphoma and other hematologic malignancies.She earned her medical degree magna cum laude from the University at Buffalo Jacobs School of Medicine and Biomedical Sciences in Buffalo, N.Y. She then completed an internal medicine residency and a hematology-oncology fellowship at Beth Israel Deaconess Medical Center in Boston, where she was a clinical fellow at Harvard Medical School. In Boston, she also did research training at the Dana Farber Cancer Institute in the lab of Dr. Anthony Letai, studying the Bcl-2 family of proteins and its role as a therapeutic target and source of therapy resistance in lymphomas.Her research focus is on lymphoma and BCL-2 family proteins in the regulation of apoptosis, or normal cell death. She is an active member of the American Society of Hematology, a member of the Southwest Oncology Group's Lymphoma Working Group and the University of California Hematologic Malignancies Consortium. Her goal is to help design and conduct innovative clinical trials for patients with lymphoma. Dr. Brem is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Brem is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.

Dr. Sandy Liu is a board-certified UCI Health medical oncologist who specializes in the treatment of genitourinary malignancies, including prostate, bladder, kidney and testicular cancers. She is dedicated to advancing the field of genitourinary oncology through innovative clinical research, multidisciplinary collaboration and the delivery of personalized, evidence-based cancer care.Liu's clinical expertise focuses on the management of advanced genitourinary cancers, with particular interests in immunotherapy, theranostics, biomarker-driven precision oncology and novel therapeutic approaches for patients with complex or treatment-resistant disease. She is actively involved in the development and conduct of clinical trials, with the goal of expanding access to promising therapies and accelerating the translation of scientific discoveries into improved patient outcomes.She earned her medical degree from the George Washington University School of Medicine and Health Sciences in Washington, D.C. She completed her residency in internal medicine at Cedars-Sinai Medical Center in Los Angeles, followed by a fellowship in hematology and medical oncology at the David Geffen School of Medicine at UCLA.As a clinical investigator, Liu has authored numerous peer-reviewed publications and is committed to advancing the science of genitourinary oncology through clinical and translational research. As a dedicated educator, she enjoys mentoring medical students, residents and fellows, emphasizing thoughtful clinical reasoning, evidence-based medicine and the integration of emerging scientific advances into patient care. She is passionate about fostering intellectual curiosity and preparing the next generation of oncologists to deliver exceptional, compassionate care.Liu believes that outstanding cancer care extends beyond treating disease—it requires understanding each patient's goals, values and individual journey. She partners closely with patients and their families to develop personalized treatment plans that incorporate the latest advances in cancer therapy while prioritizing quality of life. Her philosophy is to care for every patient with the same compassion, respect and dedication she would offer her own family.Outside of medicine, Liu enjoys traveling, staying active at the gym and spending quality time with her three children. Dr. Liu is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, and Muscle Invasive Bladder Cancer. Dr. Liu is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Medical Oncology.

Dr. Fa-Chyi Lee is a board-certified UCI Health hematologist and medical oncologist whose clinical focus is gastrointestinal cancers.Lee earned his medical degree at Saint Louis University School of Medicine. He completed a residency in internal medicine at the University of Texas Southwestern Medical Center in Dallas, followed by a fellowship in hematology and medical oncology at UCLA’s David Geffen School of Medicine.After working in private practice in Dallas, Lee joined the University of New Mexico, where he served as director of its gastrointestinal oncology group. Lee’s goal is to continue teaching and developing protocols that provide excellent patient care. Dr. Lee is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, and Familial Colorectal Cancer.